Literature DB >> 6186123

Tolerability and diagnostic usefulness of iohexol in urography. An open multicentre clinical trial.

K Levorstad, A Kolbenstvedt, S C Sommerfelt, B E Zachrisson, R Jagenburg, M Egeblad, N Thrane Nielsen, S Sjöberg, J Oldbring, K Sveen.   

Abstract

The first experience with iohexol in urography in humans is reported. Injection of iohexol in a dose of 200 mg I/kg body weight into 34 patients with normal renal function was followed by only few and slight subjective adverse effects. A large number of laboratory tests revealed no toxic effects. High radiographic contrast was obtained.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6186123     DOI: 10.1177/028418518202300509

Source DB:  PubMed          Journal:  Acta Radiol Diagn (Stockh)        ISSN: 0567-8056


  4 in total

1.  Comparison of iohexol 300 mg I/ml and Hexabrix 320 mg I/ml in central angiography. A double-blind trial.

Authors:  J Valk; F Crezée; R G Olislagers-de Slegte
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

2.  Contrast enhanced brain CT. Comparison between iohexol and metrizoate.

Authors:  S Holtås; S Cronqvist; T Renaa
Journal:  Neuroradiology       Date:  1983       Impact factor: 2.804

3.  Cerebral angiography with iohexol. A comparison with metrizamide in man.

Authors:  S Holtås; S Cronqvist; T Renaa
Journal:  Neuroradiology       Date:  1983       Impact factor: 2.804

4.  Cerebral angiography with the non-ionic water-soluble contrast medium iohexol and meglumine-Ca-metrizoate. A randomized double blind parallel study in man.

Authors:  P Nakstad; O Sortland; O Aaserud; A Lundervold
Journal:  Neuroradiology       Date:  1982       Impact factor: 2.804

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.